Philipp König

Development of the first non-hydroxamate selective HDAC6 degraders

Tim Keuler, Beate König, Nico Bückreiß et al. · Chemical Communications · 2022 · 41 citations

Life Sciences, Biochemistry, Molecular Biology +9

Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation

Laura Sinatra, Anja Vogelmann, F Friedrich et al. · Journal of Medicinal Chemistry · 2023 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells

Kathleen Wantoch von Rekowski, Philipp König, Svenja Henze et al. · Biomolecules · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies

Kathleen Wantoch von Rekowski, Philipp König, Svenja Henze et al. · International Journal of Molecular Sciences · 2020 · 16 citations · Full text

Medicine, Cell Biology, Oncology +14

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor

Nourhan Hassan, Nico Bückreiß, Janes Efing et al. · Cells · 2023 · 13 citations · Full text

Life Sciences, Cancer Biology, Oncology +14